Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
A 2016 review of 2 randomized clinical trials and 3 prospective studies concluded that oral B12 at 1,000 mcg a day was a safe and effective alternative to intramuscular injections
Pain and Irritation at Injection Site The most common reaction to B12 injections is pain, redness, swelling, or irritation, where the needle goes into your skin or muscle
There is no risk of dangerous overdose from typical multivitamins alongside the shot, but any more than that (like multiple high-dose supplements) should be avoided
Those with problems absorbing B12 from the stomach are often given hydroxocobalamin, an injectable form of B12
During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
BPC-157 and PRP are increasingly used together
